EMBRYOTROPIC PROPERTIES OF A NEW COMPOSITION OF FENBENDAZOLE AND ALBENDAZOLE (PANAVERM PLUS)
The drug Panaverm plus administered at the doses of 10,0; 15,0; 25,0; 35,0 and 45,0 mg/kg body weight (by 4.5 times increased dose) showed no embryotropic activity. Panaverm plus used at the dose of 55,0 mg / kg body weight did not cause changes in the development of embryos, except one case of hy...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Federal Scientific Centre VIEV
2016-05-01
|
| Series: | Российский паразитологический журнал |
| Subjects: | |
| Online Access: | https://vniigis.elpub.ru/jour/article/view/176 |